Longevity biotechnology has the potential to become one of the most valuable industries in the world. Additional years of life might place a greater burden on society (think of the “gray tsunami” narrative) or might deliver tremendous benefits if those extra years are spent in great cognitive and physical health.

How much value is at stake?

This is exactly what the Longevity Economics Institute specializes in. We’re also exploring how to measure this value, how to select the most efficient ways to allocate resources, how to approach valuation of longevity biotech startups, and other related questions.